Psychiatry and Neurology, Neurology · Fairfield, CT
NPI
1033176896
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
75 Kings Highway Cutoff, 5th Floor
Fairfield, CT, 06824
Phone (203) 333-1133
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.1M
2,031 prescriptions
Company payments, 2025
$411K
From 53 companies
Medicare prescription drug claims, 2024
In 2024, the drug Peter J McAllister prescribed most often to Medicare patients was Sumatriptan Succinate, with 92 prescriptions and refills. In total Peter J McAllister wrote 2,031 Medicare prescriptions that cost $2.1M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-08-01.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Sumatriptan Succinate Generic | 92 | 125 | 18 | $11K |
| Duloxetine Hcl Generic | 73 | 124 | 14 | $1,972 |
| Botox Onabotulinumtoxina | 60 | 159 | 21 | $80K |
| Gabapentin Generic | 55 | 99 | 16 | $1,239 |
| Alprazolam Generic | 52 | 53 | Under 11 | $354 |
| Bupropion Xl Bupropion Hcl | 49 | 77 | 12 | $955 |
| Donepezil Hcl Generic | 48 | 98 | 15 | $789 |
| Oxycodone Hcl Generic | 48 | 48 | 12 | $869 |
| Clonazepam Generic | 47 | 53 | 14 | $621 |
| Qulipta Atogepant | 46 | 64 | Under 11 | $68K |
| Escitalopram Oxalate Generic | 44 | 89 | 12 | $691 |
| Lorazepam Generic | 44 | 52 | 15 | $379 |
| Quetiapine Fumarate Generic | 38 | 41 | Under 11 | $430 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 36 | 36 | Under 11 | $450K |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 35 | 35 | Under 11 | $417K |
Brand drugs: - claims; generic drugs: 1,514 claims; opioid claims: 115.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter J McAllister $411K ($406K in general payments such as food, travel and fees and $5,128 for research) from 53 companies. The largest payer was Abbvie Inc. with $128K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 165 | $128K |
| Lilly USA, LLC LLY | 72 | $96K |
| H. Lundbeck A S HLUN-A.CO | 16 | $57K |
| Axsome Therapeutics, Inc. AXSM | 51 | $33K |
| Pfizer Inc. PFE | 49 | $28K |
| Merz Pharmaceuticals, LLC | 3 | $15K |
| Dompe US, Inc. | 9 | $14K |
| ANI Pharmaceuticals, Inc. ANIP | 11 | $14K |
| Eli Lilly and Company LLY | 9 | $11K |
| Pfizer International LLC PFE | 2 | $4,800 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.